Methoxetamine - a novel recreational drug with potent hallucinogenic properties

Toxicology Letters

Volumn 230, Issue 3, 2014, Pages 402-407

  Zawilska, Jolanta B ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hallucinogenic dissociative drugs; Methoxetamine; Novel psychoactive substances; Toxidrome

Indexed keywords

KETAMINE; METHOXETAMINE; PSYCHEDELIC AGENT; RECREATIONAL DRUG; UNCLASSIFIED DRUG; 2-(3-METHOXYPHENYL)-2-(ETHYLAMINO)CYCLOHEXANONE; CYCLOHEXANONE DERIVATIVE; CYCLOHEXYLAMINE DERIVATIVE; STREET DRUG;

DRUG ABUSE; DRUG DETERMINATION; DRUG EFFECT; DRUG FATALITY; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; HEALTH HAZARD; HUMAN; PREVALENCE; REVIEW; CHEMISTRY; SUBSTANCE-RELATED DISORDERS; TOXICITY;

CYCLOHEXANONES; CYCLOHEXYLAMINES; HALLUCINOGENS; HUMANS; KETAMINE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84910068718     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.08.011     Document Type: Review

References (40)

1. Abe E., Ricard F., Darrouzain F., Alvarez J.C. An automated method for measurement of methoxetamine in human plasma by use of turbulent flow on-line extraction coupled with liquid chromatography and mass spectrometric detection. Anal. Bioanal. Chem. 2013, 405:239-245.
2. Al-Saffar Y., Stephanson N.N., Beck O. Multicomponent LC-MS/MS screening method for detection of new psychoactive drugs, legal highs, in urine - experience from the Swedish population. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 930:112-120.
3. Chiappini S., Claridge H., Cockery J., Goodair C., Loi B., Schifano F. Special M related fatalities in the UK. Res. Adv. Psychiatry 2014, 1(Suppl. 1):38.
4. Corazza O., Assi S., Schifano F. From special K to special M: the evolution of the recreational use of ketamine and methoxetamine. CNS Neurosci. Ther. 2013, 19:454-460.
5. Corazza O., Schifano F., Simonato P., Fergus S., Assi S., Stair J., Corkery J., Trincas G., Deluca P., Davey Z., Blaszko U., Demetrovics Z., Moskalewicz J., Enea A., di Melchiorre G., Mervo B., di Furia L., Farre M., Flesland L., Pasinetti M., Pezzolesi C., Pisarska A., Shapiro H., Siemann H., Skutle A., Enea A., di Melchiorre G., Sferrazza E., Torrens M., van der Kreeft P., Zummo D., Scherbaum N. Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine. Hum. Psychopharmacol. 2012, 27:145-149.
6. Dargan P.I., Tang H.C., Liang W., Wood D.M., Yew D.T. Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. Clin. Toxicol. (Phila.) 2014, 52:176-180.
7. Davidson C., Hashemi G., Gant A., Fergus S., Benha C., Lione L. Effects of methoxetamine in rat bladder and nucleus accumbens brain tissue. Res. Adv. Psychiatry 2014, 1(Suppl. 1):39.
8. De Paoli G., Brandt S.D., Wallach J., Archer R.P., Pounder D.J. From street to laboratory: analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determinations in three biological matrices. J. Analyt. Toxicol. 2013, 37:277-283.
9. Elian A.A., Hacket J. A polydrug intoxication involving methoxetamine in a drugs and driving case. J. Forensic Sci. 2014, 59:854-858.
10. EMCDDA, 2013. EU drug markets reports. A strategic analysis. Available at (retrieved 9.06.14.). http://www.emcdda.europa.eu/publications/joint-publications/drug-markets.
11. EMCDDA, 2013. Methoxetamine. EMCDDA - Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino) cyclohexanone). Available at. (retrieved 15.05.14.). http://www.emcdda.europa.eu/attachements.cfm/att_222602_EN_TDAS14004ENN-1.pdf.
12. EMCDDA, 2014. European Drug Report 2014. Available at. (retrieved 30.05.14.). http://www.emcdda.europa.eu/edr2014.
13. Erowid, 2012. Available at (retrieved 9.06.13.). http://https://www.erowid.org/experiences/exp.php%3FID=97506.
14. Giné C.V., Espinosa I.F., Vilamala M.V. New psychoactive substance as adulterants of controlled drugs. A worrying phenomenon?. Drug Test Anal. 2014, 6:819-824.
15. Hill S.L., Harbon S.C., Coulson J., Cooper G.A., Jackson G., Lupton D.J., Vale J.A., Thomas S.H. Methoxetamine toxicity reported to the National Poisons Information Service: clinical characteristics and patterns of enquiries (including the period of the introduction of the UK's first Temporary Class Drug Order). Emerg. Med. J. 2014, 31:45-47.
16. Hofer K.E., Grager B., Müller D.M., Rauber-Lüthy C., Kupferschmidt H., Rentsch K.M., Ceschi A. Ketamine-like effects after recreational use of methoxetamine. Ann. Emerg. Med. 2012, 60:97-99.
17. Home Office, 2013. Available at. (retrieved 9.07.14.). http://https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/170610/offence-recording-codes.pdf.
18. Hydzik P., Gomółka E., Sulka A., Cudzik-Czop S. Acute methoxetamine poisoning - case report. Problems Forensic Sci. 2012, 91:235-242.
19. Imbert L., Boucher A., Delhome G., Cueto T., Boudinaud M., Maublanc J., Dulaurent S., Descotes J., Lachâtre G., Gaulier J.M. Analytical findings of an acute intoxication after inhalation of methoxetamine. J. Anal. Toxicol. 2014, 10.1093/jat/bku052.
20. Johnson L.A., Johnson R.L., Portier R.B. Current legal highs. J. Emerg. Med. 2013, 44:1108-1115.
21. Kjellgren A., Jonsson K. Methoxetamine (MXE): a phenomenological study of experiences induced by a legal high from the Internet. J. Psych. Drugs 2013, 45:276-286.
22. Loeffler G., Craig C. Methoxetamine misuse and toxicity. J. Stud. Alcohol Drugs 2013, 74:816-817.
23. Łukasik-Głebocka M., Sommerfeld K., Zielińska-Psuja B., Druzdz A. Acute methoxetamine intoxication - case report with serum and urine concentrations. Przegl. Lek. 2013, 70:671-673.
24. Menzies E.L., Hudson S.C., Dargan P.I., Parkin M.C., Wood D.M., Kicman A.T. Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine. Drug Test. Anal. 2014, 5:506-515.
25. Meyer M.R., Bach M., Welter J., Bovens M., Turcant A., Maurer H.H. Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn. Anal. Bioanal. Chem. 2013, 405:6307-6321.
26. Morgan C.J.A., Curran H.V. Ketamine use: a review. Addiction 2011, 107:27-38.
27. Morris H., Wallach J. From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Test. Anal. 2014, 6:214-232.
28. Östberg L.L., Hultén P., Al-Saffar Y. Methoxetamine: a case series of analytically confirmed cases. Clin. Toxicol. (Phila.) 2013, 51:257-258.
29. Papaseit E., Farré M., Schifano F., Torrens M. Emerging drugs in Europe. Curr. Opin. Psychiatry 2014, 27:242-250.
30. Roth B.L., Gibbons S., Arunotayanun W., Huang X.P., Setola V., Treble R., Iversen L. The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One 2013, 8:e59334.
31. Sein Anand J., Wiergowski M., Barwina M., Kaletha K. Accidental intoxication with high dose of methoxetamine (MXE): a case report. Przegl. Lek. 2012, 69:609-610.
32. Shields J.E., Dargan P.I., Wood D.M., Puchnarewicz M., Davies S., Waring W.S. Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. Clin. Toxicol. (Phila.) 2012, 50:438-440.
33. Soh Y.N.A., Elliott S. An investigation of the stability of emerging new psychoactive substances. Drug Test. Anal. 2014, 6:696-704.
34. Ward J., Rhyee S., Plansky J., Boyer E. Methoxetamine: a novel ketamine analog and growing health-care concern. Clin. Toxicol. (Phila.) 2011, 49:874-875.
35. Westwell A.D., Hutchings A., Caldicott D.G. The identification and chemical characterization of a new arylcyclohexylamine, methoxetamine, using a novel emergency department toxicosurveillance tool. Drug Test. Anal. 2013, 5:203-207.
36. Wiegrowski M., Anand J.S., Krzyzanowski M., Jankowski Z. Acute methoxetamine and amphetamine poisoning with fatal outcome - a case report. Int. J. Occup. Med. Environ. Health 2014, 10.2478/s13382-014-0290-8.
37. Wikström M., Thelander G., Dahlgren M., Kronstrand R. An accidental fatal intoxication with methoxetamine. J. Anal. Toxicol. 2013, 37:43-46.
38. Wood D.M., Davies S., Puchnarewicz M., Johnston A., Dargan P.I. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur. J. Clin. Pharmacol. 2012, 68:853-856.
39. Wood D.M., Hunter L., Measham F., Dargan P.I. Limited use of novel psychoactive substances in South London nightclubs. QJM 2012, 105:959-964.
40. Zawilska J.B. Legal highs - new players in the old drama. Curr. Drug Abuse Rev. 2011, 4:122-130.